Top news of the week: 06.12.2022.
SonoThera Bags $60M for Ultrasound-Guided, Non-Viral Gene Therapy
SonoThera closed its Series A round of financing Monday, counting $60.75 million in earnings and will use these proceeds to advance its ultrasound-guided, non-viral gene therapy ...
STAT in NYC: A Look Ahead at Biotech in 2023
In the markets, and perhaps in the world, doom and gloom pervade. Yet, at the same time, science continues to move forward at a stunning pace, with bi
Sana reshuffles drug pipeline, becoming latest biotech to cut staff
The richly funded drugmaker will cut 15% of its workforce, or about 75 employees, as well as stop work on one of its preclinical research programs.
Vaxxas Appoints Doug Cubbin as Chief Financial Officer
Vaxxas Appoints Doug Cubbin as Chief Financial Officer - read this article along with other careers information, tips and advice on BioSpace
Hot Topics in Biopharma: Initial Impact of Digital, Data Dilemmas in Clinical Studies, and the Search for ‘New Normal’
For today: topics relevant to many drug developers (and others): The initial impact of digital The dilemma of data collection in early clinical studies The elusive search for “new normal” ...
Gene editing startup iECURE returns to investors for fresh funding
The company, which draws on research by Jim Wilson’s lab at UPenn, says the $65 million it raised will support the start of human testing of its lead drug through to initial clinical data.
General Catalyst Backs Clinical Trials Startup Vial
Venture firm General Catalyst has led a new investment in Vial Health Technology, a startup whose technology and services are designed to help biotechnology companies run faster and ...
Why Tech Should Answer the Call of Biden’s Bioeconomy Executive Order
President Biden’s executive order to advance our national bioeconomy highlighted the tension between the amazing scientific innovation over the last 10 years and the need for our biotech ...